Black Rock Inc. Tarsus Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,652,680 shares of TARS stock, worth $72.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,652,680

Previous 2,516,139 5.43%

Holding current value

$72.1 Million

Previous $51 Million 89.25%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$19.61 - $39.22 $2.68 Million - $5.36 Million	136,541 Added 5.43%	2,652,680 $96.4 Million
Q4 2023 Feb 13, 2024	BUY	$12.98 - $20.73 $3.97 Million - $6.34 Million	305,816 Added 13.84%	2,516,139 $51 Million
Q3 2023 Nov 13, 2023	BUY	$14.75 - $24.62 $155,907 - $260,233	10,570 Added 0.48%	2,210,323 $39.3 Million
Q2 2023 Aug 11, 2023	BUY	$11.57 - $19.63 $8.59 Million - $14.6 Million	742,493 Added 50.95%	2,199,753 $39.7 Million
Q1 2023 May 12, 2023	BUY	$11.92 - $16.27 $1.38 Million - $1.89 Million	116,001 Added 8.65%	1,457,260 $18.3 Million

Q4 2022 Feb 13, 2023	BUY	$14.12 - $18.72 $3.14 Million - $4.17 Million	222,498 Added 19.89%	1,341,259 $19.7 Million
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $1.45 Million - $1.91 Million	103,128 Added 10.15%	1,118,761 $19.2 Million
Q2 2022 Aug 12, 2022	BUY	$11.08 - $19.08 $6.38 Million - $11 Million	575,675 Added 130.85%	1,015,633 $14.8 Million
Q1 2022 May 12, 2022	SELL	$14.49 - $24.28 $130,410 - $218,520	-9,000 Reduced 2.0%	439,958 $7.4 Million
Q4 2021 Feb 10, 2022	BUY	$21.21 - $29.68 $155,638 - $217,791	7,338 Added 1.66%	448,958 $10.1 Million
Q3 2021 Nov 09, 2021	BUY	$21.45 - $29.22 $70,012 - $95,374	3,264 Added 0.74%	441,620 $9.52 Million
Q2 2021 Aug 11, 2021	BUY	$27.16 - $38.59 $11.9 Million - $16.9 Million	438,356 New	438,356 $12.7 Million

Others Institutions Holding TARS

# of Institutions

166

Shares Held

39.5M

Call Options Held

190K

Put Options Held

92.9K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $725M
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account